Ireland[爱尔兰药品]

Norvir 100 mg film-coated tabletsRitonavir

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-14 　查阅全文...

Norvir 80 mg/ml oral solutionRitonavir

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-14 　查阅全文...

Vectibix 20 mg/ml concentrate for solution for infusion.Pani

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-14 　查阅全文...

Eylea 40mg/ml solution for injection in a vial

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-13 　查阅全文...

Nplate 250 micrograms powder for solution for injection Npla

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-12 　查阅全文...

Glivec 100 mg film-coated tabletsGlivec 400mg film-coated ta

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-12 　查阅全文...

Trobalt 50 mg film-coated tabletsTrobalt 100 mg film-coated

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-12 　查阅全文...

Arzerra 1,000 mg concentrate for solution for infusion.Ofatu

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-11 　查阅全文...

Arzerra 100 mg concentrate for solution for infusion.Ofatumu

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-11 　查阅全文...

Vidaza 25 mg/ml powder for suspension for injectionazacitidi

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-11 　查阅全文...

Arzerra 1,000 mg concentrate for solution for infusion.Ofatu

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-10 　查阅全文...

Arzerra 100 mg concentrate for solution for infusion.Ofatumu

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-10 　查阅全文...

Leukeran 2mg Film-coated TabletsChlorambucil

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2013-11-10 　查阅全文...

Bisodol Antacid Chewable TabletsCalcium Carbonate 522mgLight

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-10 　查阅全文...

Dopacard 10mg/mlConcentrate for solution for infusionDopexam

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-08 　查阅全文...

Tygacil 50 mg powder for solution for infusion.Tigecycline

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-08 　查阅全文...

MabCampath 30 mg/ml concentrate for solution for infusionAle

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2013-11-03 　查阅全文...

Exforge HCT 5 mg/160 mg/12.5 mg film-coated tabletsHydrochlo

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2013-11-02 　查阅全文...

Exforge 5 mg/160 mg film-coated tabletsValsartanAmlodipine b

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-02 　查阅全文...

Exforge 10 mg/160 mg film-coated tabletsValsartanAmlodipine

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2013-11-02 　查阅全文...

首页上一页 59 60 61 62 63 64 65 下一页尾页 62/66/1301